Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.3285 EUR -3.38% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Additional Paid In Capital Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Additional Paid In Capital
€201.4m
CAGR 3-Years
4%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Additional Paid In Capital
€593.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Additional Paid In Capital
€446.5m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
17%
Inventiva SA
PAR:IVA
Additional Paid In Capital
€201.9m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Additional Paid In Capital
€33.6m
CAGR 3-Years
-6%
CAGR 5-Years
-26%
CAGR 10-Years
-12%
OSE Immunotherapeutics SA
PAR:OSE
Additional Paid In Capital
€76.8m
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Additional Paid In Capital?
Additional Paid In Capital
201.4m EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Additional Paid In Capital amounts to 201.4m EUR.

What is Gensight Biologics SA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
11%

Over the last year, the Additional Paid In Capital growth was 11%. The average annual Additional Paid In Capital growth rates for Gensight Biologics SA have been 4% over the past three years , 11% over the past five years .

Back to Top